In December 2025, Solventum announced updated consensus recommendations from an international panel on the clinical use of closed incision negative pressure therapy (ciNPT) with its proprietary ...

Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space in acute care settings in the U.S. "Announcing and completing our first strategic acquisition is a ...

The stock market continued to run in place to open the final full trading week of 2025. The S&P 500 and Nasdaq Composite are up in mid-teen percentages and low-20% percentages year to date, ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Solventum (SOLV) been one of those stocks this year? By ...

The S&P healthcare index (XLV) saw moderate gains in 2025, reaching a YTD increase of 12.2% by mid-December, though it fell short of its May highs. The sector is the sixth-highest performing sector ...

Artificial intelligence coding startup Zencoder today unveiled a new orchestration tool that it says will help enterprises move away from unproductive “vibe coding” to a more disciplined and ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.